• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of February 14

Video

Here are the top 5 biosimilar articles for the week of February 14, 2022.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of February 14, 2022.

Number 5: Patients treated by US Veterans Healthcare Administration who tried an infliximab biosimilar after being treated with Remicade were almost 5 times more likely to switch to another innovator biologic—with most going back to the reference product, according to a recent study.

Number 4: The year 2022 “is set to be a turning point” in the United States, as biosimilars are on their way to delivering $133 billion in aggregate savings by 2025, according to Cardinal Health's “2022 Biosimilars Report: The U.S. Journey and Path Ahead.”

Number 3: The year 2021 proved to be big for biosimilars, with 4 approvals and increased competition, signaling that FDA is shifting some of their focus from the pandemic back to the growing industry.

Number 2: Requiring patients to switch from Enbrel (etanercept) to etanercept biosimilars caused no permanent, unintended changes in patterns of health care use, suggesting the change did not harm patient health and may have even reduced disease severity, according to a Canadian study.

Number 1: Biogen and Xbrane Biopharma signed a commercialization agreement for Xcimzane, a certolizumab pegol biosimilar referencing Cimzia for the treatment of rheumatoid arthritis, psoriasis, and other rheumatologic conditions.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Sophia Humphreys, PharmD
The Top 5 Biosimilar Articles of the Week.
The Top 5 Biosimilar Articles of the Week.
Here are the top 5 biosimilar articles for the week of October 21, 2024.
Sophia Humphreys, PharmD
Here are the top 5 biosimilar articles for the week of October 14, 2024.
Ivo Abraham, PhD, RN.
Here are the top 5 biosimilar articles for the week of October 7, 2024.
Here are the top 5 biosimilar articles for the week of September 30, 2024.
Ivo Abraham, PhD, RN.
Related Content
© 2024 MJH Life Sciences

All rights reserved.